Caitlin Raymond/LinkedIn
Jan 13, 2026, 16:38
Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”New post, inspired by a case I saw on service: TTP’s Little-Known Cousin: Understanding TAMOF as a TTP-Like Process.
TAMOF is often mislabeled as DIC or dismissed as “just sepsis.”
But mechanistically, it behaves like a secondary thrombotic microangiopathy — driven by endothelial activation, ultra-large vWF, and insufficient ADAMTS13 in context.
The labs are subtle:
- Low platelets
- High LDH
- ± MAHA
- Relatively preserved coagulation studies
Seeing the pattern matters, because TAMOF may be treatable, including consideration of plasma exchange.”
Read the full post here.
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia
-
Jul 2, 2026, 19:26Dhinesh Selvaraju: FDA Expands Access to HYMPAVZI in Hemophilia
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association